share_log

Tenax Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Janus Henderson Group plc(9.9%),Janus Henderson Biotech Innovation Master Fund Ltd(9.9%)

SEC ·  Aug 15, 2024 03:20
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.